Richard R. DeLuca - 27 Jan 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Richard R. DeLuca, Jr.
Issuer symbol
MRK
Transactions as of
27 Jan 2025
Net transactions value
+$2,491,398
Form type
4
Filing time
29 Jan 2025, 18:14:21 UTC
Previous filing
06 May 2024
Next filing
01 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Award $2,491,398 +25,438 +17% $97.94 178,993 27 Jan 2025 Direct F1, F2
holding MRK Common Stock - 401(k) Plan 1,266 27 Jan 2025 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/22. Performance shares were paid out at 169 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2024.
F2 Holdings include shares acquired in dividend reinvestment transactions.
F3 Includes shares acquired and dividends earned through January 8, 2025 in the Merck U.S. Savings Plan, a 401(k) plan.